Nolato AB (publ) (STO:NOLA.B)
56.50
-0.60 (-1.05%)
Oct 15, 2026, 3:23 PM CET
Nolato AB Market Cap
Nolato AB has a market cap or net worth of 15.22 billion as of October 15, 2026. It is the 7,915th most valuable company in the world and the 101st biggest in Sweden. Its market cap has decreased by 2.16% in one year.
Market Cap
15.22B
Enterprise Value
16.50B
Revenue
9.43B
Global Rank
Country Rank
#101 Sweden
PE Ratio
21.55
ChartMarket Cap Chart
Since December 6, 1996, Nolato AB's market cap has increased from 660.32M to 15.22B, an increase of 2,204.94%. That is a compound annual growth rate of 11.07%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 15.22B | -8.57% |
| Dec 30, 2025 | 16.65B | 14.02% |
| Dec 30, 2024 | 14.60B | 2.46% |
| Dec 29, 2023 | 14.25B | -3.20% |
| Dec 30, 2022 | 14.72B | -49.35% |
| Dec 30, 2021 | 29.07B | 30.63% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Getinge AB | 69.26B |
| Sectra AB | 60.46B |
| Elekta AB | 21.88B |
| Vitrolife AB | 12.89B |
| MedCap AB | 7.90B |
| Xvivo Perfusion AB | 6.62B |
| CellaVision AB | 3.89B |
| BICO Group AB | 1.69B |